Future of anti-PD-1/PD-L1 applications: Combinations with other therapeutic regimens

Mengjia Song, Xinfeng Chen, Liping Wang, Yi Zhang

2018, 30(2): 157-172. doi: 10.21147/j.issn.1000-9604.2018.02.01

Tumor immunotherapy: New aspects of natural killer cells

Yangxi Li, Rui Sun

2018, 30(2): 173-196. doi: 10.21147/j.issn.1000-9604.2018.02.02

Systemic therapy for cervical carcinoma – current status

Krystyna Serkies, Jacek Jassem

2018, 30(2): 209-221. doi: 10.21147/j.issn.1000-9604.2018.02.04

Impact of 5-Fu/oxaliplatin on mouse dendritic cells and synergetic effect with a colon cancer vaccine

Xinqiang Hong, Tiangeng Dong, Tuo Yi, Jianwei Hu, Zhen Zhang, Shengli Lin, Weixin Niu

2018, 30(2): 197-208. doi: 10.21147/j.issn.1000-9604.2018.02.03

A nomogram to predict adjuvant chemotherapy recommendation in breast cancer patients with intermediate recurrence score

Feilin Qu, Xiaosong Chen, Xiaochun Fei, Lin Lin, Weiqi Gao, Yu Zong, Jiayi Wu, Ou Huang, Jianrong He, Li Zhu, Weiguo Chen, Yafen Li, Kunwei Shen

2018, 30(2): 222-230. doi: 10.21147/j.issn.1000-9604.2018.02.05

A multicenter hospital-based diagnosis study of automated breast ultrasound system in detecting breast cancer among Chinese women

Xi Zhang, Xi Lin, Yanjuan Tan, Ying Zhu, Hui Wang, Ruimei Feng, Guoxue Tang, Xiang Zhou, Anhua Li, Youlin Qiao

2018, 30(2): 231-239. doi: 10.21147/j.issn.1000-9604.2018.02.06

Health-related quality of life among rural residents aged 45−69 years in Hua County, Henan Province, China: Results of ESECC Trial for esophageal cancer screening with endoscopy

Hui Wang, Yaqi Pan, Chuanhai Guo, Fenglei Li, Ruiping Xu, Mengfei Liu, Zhen Liu, Fangfang Liu, Hong Cai, Yang Ke, Zhonghu He

2018, 30(2): 240-253. doi: 10.21147/j.issn.1000-9604.2018.02.07

Elevated preoperative plasma D-dimer dose not adversely affect survival of gastric cancer after gastrectomy with curative intent: A propensity score analysis

Yuexiang Liang, Donglei He, Liangliang Wu, Xuewei Ding, Xiaona Wang, Baogui Wang, Rupeng Zhang, Han Liang

2018, 30(2): 254-262. doi: 10.21147/j.issn.1000-9604.2018.02.08

Feasibility of differentiating T3 from T4a gastric cancer in different Lauren classification by determining serosa invasion: Diagnostic performance of high enhanced serosa sign

Rui-Jia Sun, Lei Tang, Ying Chen, Xiao-Ting Li, Yu Sun, Zi-Yu Li, Ying-Shi Sun

2018, 30(2): 263-271. doi: 10.21147/j.issn.1000-9604.2018.02.09

Long-term outcomes in patients with ypT0 rectal cancer after neoadjuvant chemoradiotherapy and curative resection

Zhao Lu, Pu Cheng, Fu Yang, Zhaoxu Zheng, Xishan Wang

2018, 30(2): 272-281. doi: 10.21147/j.issn.1000-9604.2018.02.10

IGHG1 promotes motility likely through epithelial-mesenchymal transition in ovarian cancer

Jingfeng Qian, Fangxing Ji, Xue Ye, Hongyan Cheng, Ruiqiong Ma, Xiaohong Chang, Chengchao Shou, Heng Cui

2018, 30(2): 282-290. doi: 10.21147/j.issn.1000-9604.2018.02.11